Key facts
- This page summarizes Choon Choong Hau's Form 4 filing for TITAN PHARMACEUTICALS INC (TTNP).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 27 Mar 2024, 09:45.
Choon Choong Hau - 18 Mar 2024 Form 4 Insider Report for TITAN PHARMACEUTICALS INC (TTNP)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- TTNP
- Reported as of
- 18 Mar 2024
- Net transaction value
- -$500,000
- SEC form
- 4
- Accepted by SEC
- 27 Mar 2024, 09:45:40 UTC
- Prior SEC filing
- 20 Jul 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Choon Choong Hau
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Choon Choong Hau filed Form 4 for TITAN PHARMACEUTICALS INC (TTNP) on 27 Mar 2024.
Change
- Previous filing in this sequence was filed on 20 Jul 2023.
- Current net transaction value: -$500,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TTNP
transaction
Common Stock
Conversion of derivative security
- Transaction value
- $0
- Shares
- +54,132
- Change %
- +1.4%
- Price
- $0.000000
- Shares after
- 3,802,100
- Date
- 18 Mar 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TTNP
transaction
Derivative
Convertible Promissory Note
Conversion of derivative security
- Transaction value
- $500,000
- Shares
- Change %
- Price
- Shares after
- 0
- Date
- 18 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 54,132
- Exercise price
- $9.32
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
On March 18, 2024, the Reporting Person converted an aggregate of $500,000 of the outstanding principal and $6,444.44 of the outstanding accrued interest, including $1,933.33 of tax withholding on interest earned, for a total sum payable of $504,501.11 under the Convertible Promissory Note issued by Issuer dated August 8, 2023. After giving effect to the conversion, as of the date of this Form 4, there are no outstanding in principal or in accrued interest outstanding under the Convertible Promissory Note.